Breaking the pandemic cycle and preventing future global health crises requires sustained public and private sector funding in vaccines. In our latest video, learn why we must quantify the value of vaccines to drive these key investments.
Amplifying this powerful public health tool lies in quantifying its full value.
Given all that the world has lost to COVID-19, it’s hard to ignore the importance of preventing infectious diseases—yet if history repeats itself, that is exactly what will happen: another spin of the public health cycle of panic and neglect.
One approach to breaking this cycle is to demonstrate the full value of key public health tools such as influenza vaccines, which save livelihoods as well as lives. Listen as researchers and policy experts make the case for public and private investment in developing next-generation influenza vaccines.
Featuring: Moses Alobo, Cheryl Cohen, Julie Gerberding, Margaret Hamburg, Ben Jones, Gagandeep Kang, Gerald Keusch, Jerome Kim, Florian Krammer, Andrew Lo, Marianna Mazzucato, Kanta Subbarao and Eric Topol.
To learn more, read our latest article with Nature Research Custom Media, “Revealing the hidden value of vaccines.”